The use of imaging is a crucial part of radiotherapy (RT), and it is used to localize both tumours and sensitive organs. Imaging is also the input to treatment planning calculations and for patient set-up. Magnetic resonance (MR) imaging provides excellent soft tissue contrast, and it also offers functional information of the tissues. Therefore, a major argument for replacing CT with MR in the RT process is the significantly improved spatial definition of target and risk organ volumes. However, in order to fully integrate MR into the RT workflow, CT-information also needs to be replaced by MR-data for accurate dose calculations and generation of reference images for patient positioning. Accordingly, the MR-only scenario in RT requires a substantial amount of research, development and hard work, before it can be brought into clinical practice. In Sweden, we have addressed the task by a national network called the "Gentle Radiotherapy" project, which was initiated in 2014. The aims of the project are to facilitate a fully integrated MR in the workflow of RT, and to promote the use of MR in clinical studies. The project is supported by the "Swedish Innovation Agency" (VINNOVA). The members of the consortium are six University Hospitals and six industrial partners. The work is divided into five dedicated work packages (WP): 1) Optimisation of sequences and protocols for RT applications, 2) MR-based treatment planning, 3) Image registration and automatic segmentation, 4) Q/A of MR-only workflow, and 5) 'Functional MRI' and clinical studies. About 50 researchers and clinicians are actively working in the five work packages, but even further scientists are involved. The mixture of clinical practice, academic science and industrial innovation creates a vibrant research environment. Besides the national project meetings, an educational series of web-based seminars on relevant topics of MR in RT is being developed. The expected final outcome of the project is clinical procedures, scientific research as well as new industrial products. The present status of the national Gentle radiotherapy project will be reviewed and a few results will be presented. In one subproject of Gentle Radiotherapy methods for creating CT equivalent data from MR-images are studied, i.e. synthetic CT images (sCT) for MR-only workflow. The Statistical Decomposition Algorithm (SDA) automatically decomposes and analyzes a standard type MRI image volume with respect to a plurality of tissue types, using a template assisted classification method. In a preliminary study, sCT images generated by the SDA were evaluated by comparing dosimetric accuracy between sCT and conventional CT for a set of six prostate tumor patients. Average mean absorbed dose difference to target was 0.1±0.2% (1 s.d.) between CT and sCT. Even with a restrictive gamma criteria (2% local dose/1mm), the pass rate was exceeding 99.9% in the transversal isocenter plane (superficial points excluded) for all cases. A study including more patients is in progress. This study is a good example of how an industrial partner works closely with academia/clinic in order to develop a new tool.
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Generation of density maps for dose calculations from MRI using atlas methods P.B. Greer 1 , J. Dowling 2 , D. Rivest-Henault 2 , S. Ghose 2 , P. Pichler 1 , J. Sun 3 , H. Richardson 1 , F. Menk 3 , J. Martin 1 , C. Wratten 1 1 Calvary Mater Newcastle, Radiation Oncology, Newcastle, Australia 2 CSIRO, Australian E-Health Research Centre, Brisbane, Australia 3 University of Newcastle, Mathematical and Physical Sciences, Newcastle, Australia Introduction: Several different methods of mapping electron densities to MRI scans for dose calculation purposes have been proposed. These can be broadly grouped into classification based methods or atlas based methods. The classification methods estimate the tissue type from the MRI signal using single or multiple MRI scan sequences and assign an appropriate density. The atlas based methods use deformable image registration techniques to register single or multiple MRI atlas scans to a patient MRI scan and then assign densities. In this work a method that combines multiatlas deformable registration to the patient MR scan and local weighted voting to assign a CT value to each voxel of the MR planning scan has been developed and tested. Methods: Forty men with ages ranging from 58 to 78 undergoing prostate cancer radiation therapy treatment were scanned under a research protocol. Patients were positioned at MR in the treatment position on a Siemens Skyra 3T scanner. The planning MR sequence was a 3D, T2 weighted 1.6 mm isotropic voxel SPACE sequence with field-of-view to cover the entire pelvis (ranging from 38 -45 cm 2 ) acquired in 6 mins 40 s. All scans were contoured by 3 experienced observers. A conventional CT scan was acquired for the patient treatment plan, atlas generation, and to compare dose calculations. The atlas database is created by deformable registeration of the patient MR scan to the corresponding patient CT scan to form conjugate MR-CT pairs. To create synthetic CT scans from a subsequent patient planning MR scan the following steps are used: 1) each atlas MR scan is deformably registered to the patient planning MR scan; 2) for small voxel regions of the patient planning MR, the intensity is compared to the same voxel in all the registered atlas MR scans; 3) each atlas scan is assigned a weighting according to the similarity of the voxel values with the most similar having the highest weighting with all assigned weights summing to 1; 4) the CT values from the corresponding voxel of the conjugate CT atlas scans are added together using the previously determined weightings to provide the CT intensity value of that voxel of the synthetic CT scan. Results: Dose comparisons between the CT and synthetic CT scans created from the MR with the Eclipse AAA algorithm had an average difference of 0.3% and standard deviation of 0.7% with tests performed using a leave-one-out approach. Gold fiducials are automatically segmented from MR scans (small field of view T1 flip 80 sequence) for image-guidance. Distortions and geometric accuracy of digitally reconstructed radiographs were tested with geometric phantoms and were within 1 mm of CT based values. Conclusions: MR-only planning using atlas-based electron density mapping to create synthetic CT scans for dose calculations has been shown to be an accurate method for prostate treatment planning. The method requires only a single conventional T2 weighted MR sequence. A prospective study using MR-only planning is currently in development to translate the MR-only workflow to clinical practice at our institution.
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In a MR-only workflow, the planning CT scan used in the preparation of a radiotherapy treatment is replaced by MRI. MRI already outperforms CT in target and OAR definition in many cases, but for treatment planning the MRI is usually registered to a planning CT scan. For MR-only, the MRI scan is also needed for RT dose planning and image-guided radiotherapy at the treatment machine. The MR-only workflow allows us to abolish two preparation steps: the acquisition of the planning CT and the subsequent, registration of the planning CT with MRI. As the latter step can be inaccurate, the MR-only workflow improves both patient comfort and the accuracy of target localisation. For dose planning, electron densities now need to be derived from the MRI. Several methods have been developed for this purpose. One solution is to classify the tissue types in an MRI scan and assign Hounsfield Units (HU) accordingly. Errors in the Hounsfield Unit assignment can result in wrong dose deposition to both target and OAR. Therefore, QA of these scans is crucial for the RT chain. Since there is no CT scan available, the Hounsfield Unit map derived from MRI cannot be cross-checked with a regular planning CT. Although methods to derive a HU map from MRI are increasingly accurate, image artefacts in the MR scans themselves may corrupt the result. For example, an unnoticed paperclip in the scanner results in distorted MRI scans. For this reason, QA has to be performed for each patient. Since this will be time-consuming, smart strategies are needed. In-vivo EPID dosimetry checks the consistency in the whole RT chain. Therefore, it is a suitable way to verify the integrity of the HU map derived from the MRI scan. The patient representation is checked by measuring transmission directly behind the patient with the EPID panel and comparing it with the calculated transmission from the MRI-derived HU map. The in-vivo EPID dosimetry method is fully automatic and easily performed for each individual patient. Furthermore, any significant under-or over dosage caused by an inconsistent HU assignment is reported in 3D. We tested the in-vivo dosimetry method for MR-only QA for the pelvic case. MR-only data was collected for prostate and rectum cancer patients on a Philips 3.0T MR system in treatment position on a flat table top. A 6-element phasedarray coil was strapped loosely on the pelvis to minimize body contour deformation. From the conventional MR DIXON scans, water and fat were classified. Bone was segmented with an atlas labelling technique into cortical bone and bone marrow. Subsequently, the clinical CT based VMAT plans were recalculated on MRI-derived HU maps with the same set of Monitor Units. The plans were compared using gamma evaluation and clinical dose parameters. In-vivo measured EPID dose of the first three fractions was back-projected to the patient in 3D. For the MR-only workflow the transmission was calculated from the MRIderived HU map. Dose differences were evaluated with a 3%-3mm gamma criteria within the 50% isodose surface, consistent with our clinical practice. QA of a MR-only workflow is needed since errors in the MRderived HU maps directly effect dose distribution. In-vivo EPID dosimetry shows to be a promising method for QA of a MR-only workflow, since it checks the consistency in the whole RT chain in an automatic way.
